Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

Sponsor
Texas A & M University Baylor College Of Dentistry (Other)
Overall Status
Unknown status
CT.gov ID
NCT02702505
Collaborator
(none)
50
1
2
37
1.4

Study Details

Study Description

Brief Summary

Mineral trioxide aggregate has been previously FDA approved as an endodontic filler. Its use in vital teeth has demonstrated significant color change post-treatment leaving it ineffective for esthetic use..

The new formulation will be tested to see if has the same effect.

Condition or Disease Intervention/Treatment Phase
  • Biological: NeoMTA
  • Other: ProRoot MTA
Phase 4

Detailed Description

This randomized control, split-mouth trial will use 50 pediatric subjects selected from the patient population in the pediatric dental clinics at Baylor College of Dentistry and in select faculty private practices. The study will use a within-subject control design whereby one tooth will be treated with a pulpotomy using the new formulation of MTA (NeoMTA Plus, Avalon Biomed Inc., Bradenton, FL, USA) and restored with a multi-surface composite, and the other tooth with an MTA pulpotomy and restored with a SSC; thus, approximately 50 teeth will be treated for each treatment group. The restoration type will be randomized as to which side will receive the SSC or composite using sealed, opaque envelopes. Approximately 50 subjects will be needed for the study in order to elicit any significant findings as demonstrated by a power analysis from a similar study.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT
Study Start Date :
Nov 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: NeoMTA

The new formulation of MTA (does not contain bismuth oxide) will be used in one tooth receiving a pulpotomy to determine if the color of the tooth changes over time. The new formulation has received the Food and Drug Administrations 510(k) substantial equivalence clearance for Class II dental materials and is equivalent to its MTA predicate (ProRoot, Dentsply Tulsa Dental, Tulsa, OK, USA).19

Biological: NeoMTA
A new formulation of MTA was developed in which bismuth oxide was omitted

Other: ProRoot MTA

Control group. This group will receive the old formulation of MTA in the pulpotomy and the tooth will receive a full coverage stainless steel crown restoration.

Other: ProRoot MTA
Control group

Outcome Measures

Primary Outcome Measures

  1. Color stability [2 years]

    Dental intraoral photographs will evaluated

  2. Internal resorption [2 years]

    Dental radiographs will be evaluatedresorption

  3. external resorption [2 years]

    Dental radiographs will be evaluated resorption

  4. Bone loss [2 years]

    Dental radiographs will be evaluated for intraradicular or periapical bone loss

  5. Widening of periodontal ligament space [2 years]

    Dental radiographs will be evaluated for widening of the PDL space

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • • Children between the ages of 2 ½ and 8 years of age

  • Patient must have two, contralateral primary molars that are matched for type of molar (first or second), size of carious lesion (same level of approximation of carious lesion to the pulp), and arch (maxillary or mandibular) that are treatment planned for a pulpotomy

  • The teeth selected for the study must be vital and asymptomatic both clinically and radiographically or only display symptoms consistent with reversible pulptitis

  • The teeth selected for the study must be anticipated to be retained in the mouth for at least two years

  • Each patient must have an updated medical history form in the dental record, be examined by the operator, and be classified as ASA I or II (in good general health)

Exclusion Criteria:
  • Teeth with a history of spontaneous pain

  • Teeth with radiographic evidence of internal or external resorption, intraradicular or periapical bone loss, loss of lamina dura, or widening of the periodontal ligament space

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas A & M University Baylor College of Dentistry Dallas Texas United States 75246

Sponsors and Collaborators

  • Texas A & M University Baylor College Of Dentistry

Investigators

  • Principal Investigator: Carolyn A Kerins, DDS, PhD, Texas A & M University Baylor College Of Dentistry

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Carolyn A. Kerins DDS, Associate Professor and Graduate Program director, Texas A & M University Baylor College Of Dentistry
ClinicalTrials.gov Identifier:
NCT02702505
Other Study ID Numbers:
  • 072015-041
First Posted:
Mar 8, 2016
Last Update Posted:
Mar 8, 2016
Last Verified:
Mar 1, 2016
Keywords provided by Carolyn A. Kerins DDS, Associate Professor and Graduate Program director, Texas A & M University Baylor College Of Dentistry
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2016